Exact Sciences Corporation (EXAS)

Etorro trading 970x250
Exact Sciences Corporation (EXAS) Logo

About Exact Sciences Corporation

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company’s pipeline products focus on enhancing the Cologuard test’s performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Address: 5505 Endeavor Lane, Madison, WI, United States, 53719

Exact Sciences Corporation News and around…

Latest news about Exact Sciences Corporation (EXAS) common stock and company :

11 Best Genomic Stocks to Buy Now
19 Oct, 2021 Yahoo! Finance

In this article, we will take a look at the 11 best genomic stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Genomic Stocks to Buy Now. Genomics is a branch of biology that studies the structure, function, evolution, mapping, and editing of genomes, […]

AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) Among Leading Biotech Companies Innovating the Field of Early Cancer Screening and Detection
12 Oct, 2021 FinancialContent
Should I Avoid EXACT Sciences Corporation (EXAS)?
12 Oct, 2021 Yahoo! Finance

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always […]

Noteworthy Friday Option Activity: PETS, ABT, EXAS
08 Oct, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in PetMed Express Inc (PETS), where a total of 1,542 contracts have traded so far, representing approximately 154,200 underlying shares. That amounts to about 44.4% of PETS's average daily trading volume over the past month of 347,220 shares..

Exact Sciences schedules third quarter 2021 earnings call
08 Oct, 2021 Yahoo! Finance

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its third quarter 2021 financial results after the close of the U.S. financial markets on November 2, 2021. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.

Interesting EXAS Put And Call Options For November 26th
07 Oct, 2021 FinancialContent

Investors in EXACT Sciences Corp. (EXAS) saw new options become available today, for the November 26th expiration..

Interesting EXAS Put And Call Options For November 19th
06 Oct, 2021 FinancialContent

Investors in EXACT Sciences Corp. (EXAS) saw new options become available this week, for the November 19th expiration..

Interesting EXAS Put And Call Options For April 2022
05 Oct, 2021 FinancialContent

Investors in EXACT Sciences Corp. (EXAS) saw new options begin trading this week, for the April 2022 expiration..

The Math Shows ONEO Can Go To $112
04 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— Russell 1000 Momentum Focus ETF (ONEO), we found that the implied analyst target price for the ETF based upon its underlying holdings is $112.24 per unit.

The 1 Stock I'd Buy Right Now
18 Sep, 2021 FinancialContent

The pandemic isn't over yet.

Cisco Stock Should Get a Boost From a Coming Wave of Equipment Buying
18 Sep, 2021 Yahoo! Finance

The company’s best customers are likely to step up their spending. Also, Wall Street views on Electronic Arts, Exact Sciences, Albireo Pharma, Regions Financial, and Papa John’s International.

Columbia Fund Outperforms With Small Number Of Best Ideas
17 Sep, 2021 FinancialContent

Columbia Large Cap Growth Fund invests only in its managers' best ideas. That strategy has made it one of the best mutual funds.

Why Exact Sciences' Stock Is Trading Higher Today
15 Sep, 2021 FinancialContent

Exact Sciences(NASDAQ:EXAS)shares are trading higher after the company announced an expansion of its primary care sales team ...

Exact stock surges as changes to Pfizer's sales agreement a 'positive,' analyst says
15 Sep, 2021 Yahoo! Finance

Shares of Exact Sciences Corp. rallied 8.0% in afternoon trading Wednesday, after the molecular diagnostics company said it taking over the selling of its Cologuard at-home colon cancer screening test from Pfizer Inc. , and said it was discussing with Pfizer "material changes" to their promotion agreement. The company said it learned in late August that Pfizer cut the sales positions supporting its business tasked with selling Cologuard, so Exact offered those displaced sales representatives job

3 Crash-Ready Stocks to Buy in September
14 Sep, 2021 FinancialContent

History says this month can be scary. These stocks can get you through it.

This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead
06 Sep, 2021 FinancialContent

Small-cap stocks have a history of outperforming large-cap names as they have the potential for rapid growth and have event-driven moves ...

Exact Sciences to participate in September investor conferences
01 Sep, 2021 Yahoo! Finance

Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following virtual conferences and invited investors to participate by webcast.

Renalytix Appoints Daniel J. Levangie to its Board of Directors
30 Aug, 2021 FinancialContent

Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic

Will Illumina’s Purchase of Grail Kill Cancer-Test Competition?
27 Aug, 2021 Yahoo! Finance

Feds tell judge that the combined companies will unfairly monopolize the market for blood screening that can detect multiple cancers.

Why Is Exact Sciences (EXAS) Down 9.4% Since Last Earnings Report?
27 Aug, 2021 Yahoo! Finance

Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

3 Top Healthcare Stocks to Buy for August
19 Aug, 2021 FinancialContent

With excellent prospects, these three companies are built to last and today's prices are attractive.

Exact Sciences receives regulatory approval for the Oncotype DX Breast Recurrence Score® Program in Japan
16 Aug, 2021 Yahoo! Finance

Exact Sciences Corp. (Nasdaq: EXAS) today announced that Japan's Ministry of Health, Labor and Welfare (MHLW) has approved the Oncotype DX Breast Recurrence Score® Program. The test helps guide chemotherapy treatment recommendations and provides risk of distant recurrence in patients with hormone receptor-positive, HER2-negative early-stage breast cancer with up to three positive lymph nodes. MHLW approval is a critical step in making Oncotype DX® accessible to breast cancer patients in Japan.

Unusual Options Activity Insight: Exact Sciences
13 Aug, 2021 FinancialContent

Exact Sciences (NASDAQ:EXAS) shares experienced unusual options activity on Friday. The stock price moved down to $93.95 following the ...

Clinical Gastroenterology and Hepatology Publishes Data Showing Exact Sciences' Oncoguard™ Liver Liquid Biopsy Test Delivers Enhanced Performance for Early-stage Detection of Hepatocellular Carcinoma
13 Aug, 2021 Yahoo! Finance

Exact Sciences Corp. (Nasdaq: EXAS) announced today that the performance of its Oncoguard™ Liver liquid biopsy test is now published online in the peer-reviewed journal Clinical Gastroenterology and Hepatology (CGH). The test delivers 82% early-stage sensitivity, and an overall 88% sensitivity and 87% specificity1 for the detection of hepatocellular carcinoma (HCC), the leading form of liver cancer.

Exact Sciences (EXAS), A Top Detractor in RiverPark’s Q2 Results
09 Aug, 2021 Yahoo! Finance

RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here. The RiverPark Large Growth Fund (the “Fund”) returned 13.1% for the second quarter of 2021, while its benchmarks, the S&P 500 Total Return Index (“S&P”) advanced 8.5%, the Russell […]

10 Reddit’s WallStreetBets Stocks That are Tumbling
09 Aug, 2021 Yahoo! Finance

In this article, we discuss the 10 Reddit’s WallStreetBets stocks that are tumbling. If you want to skip our detailed analysis of these stocks, go directly to the 5 Reddit’s WallStreetBets Stocks That are Tumbling. Social media has been exerting an ever-greater influence on the movement of markets over the past few months. The mainstream […]

Dow Jones Futures: Market Rally Hits Highs As Apple, Tesla, Square Lead 6 Stocks Near Buy Points; What To Do Now
06 Aug, 2021 FinancialContent

The market rally is at highs, but tricky to navigate. Apple, Tesla and Square are near buy points. BioNTech earnings loom.

10 Stocks to Buy From Cathie Wood’s Fleet of ETFs
06 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The haters have come out against portfolio manager Cathie Wood. In fact, an ETF is preparing to launch that bets against her stocks to buy. The post 10 Stocks to Buy From Cathie Wood’s Fleet of ETFs  appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved
06 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Illumina will likely be allowed to buy Grail. But even without that deal, ILMN stock is very attractive, given the company's strong growth drivers. The post Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Oversold Conditions For EXACT Sciences
03 Aug, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Exact Sciences Corporation (EXAS) is a NASDAQ Common Stock listed in , ,

970x250